L-dopa level in plasma, primary condition for the kinetic effect.
作者信息
Birkmayer W, Danielcyk W, Neumayer E, Riederer P
出版信息
J Neural Transm. 1973;34(2):133-43. doi: 10.1007/BF01244666.
PMID:4722571
Abstract
摘要
相似文献
1
L-dopa level in plasma, primary condition for the kinetic effect.血浆中左旋多巴水平，这是动力学效应的首要条件。
J Neural Transm. 1973;34(2):133-43. doi: 10.1007/BF01244666.
2
Dopa-decarboxylase inhibitors.多巴脱羧酶抑制剂
Lancet. 1973 May 5;1(7810):979-80.
3
Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Neurology. 1974 May;24(5):482-6. doi: 10.1212/wnl.24.5.482.
4
Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).使用左旋多巴（美多巴R）和一种脱羧酶抑制剂（RO-46-4602）的化合物治疗帕金森症。
Acta Neurol Scand Suppl. 1972;51:121-2.
5
Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor.用左旋多巴以及左旋多巴与多巴脱羧酶抑制剂联合治疗帕金森病。
Z Neurol. 1972;202(4):347-55. doi: 10.1007/BF00316182.
6
Recent advances in the treatment of Parkinsonism with drugs.
Acta Neurol Scand Suppl. 1972;51:59-103.
7
8
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.左旋多巴联合卡比多巴治疗帕金森病患者与单用左旋多巴治疗的一年对比。
Lancet. 1973 Dec 29;2(7844):1459-62. doi: 10.1016/s0140-6736(73)92729-3.
9
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).α-甲基多巴肼（MK-486）对帕金森病左旋多巴治疗的改良作用
Trans Am Neurol Assoc. 1971;96:55-8.
10
[Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
Clin Chim Acta. 1971 Jun;33(1):111-5. doi: 10.1016/0009-8981(71)90257-9.
引用本文的文献
1
The Human Experience with Intravenous Levodopa.静脉注射左旋多巴的人体试验经历
Front Pharmacol. 2016 Jan 6;6:307. doi: 10.3389/fphar.2015.00307. eCollection 2015.
2
Antiparkinson prodrugs.抗帕金森病前体药物。
Molecules. 2008 Jan 16;13(1):46-68. doi: 10.3390/molecules13010046.
3
Intestinal absorption of levodopa in man.左旋多巴在人体肠道的吸收情况。
Eur J Clin Pharmacol. 1983;25(1):69-72. doi: 10.1007/BF00544017.
4
The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations.帕金森病患者出现开关波动时静脉注射和口服左旋多巴的药代动力学。
Br J Clin Pharmacol. 1986 Oct;22(4):429-36. doi: 10.1111/j.1365-2125.1986.tb02913.x.
5
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.单胺氧化酶-B抑制剂司立吉林增强左旋多巴治疗后的抗运动不能作用。
J Neural Transm. 1975;36(3-4):303-26. doi: 10.1007/BF01253131.
6
Clinical pharmacokinetics of levodopa in parkinson's disease.帕金森病中左旋多巴的临床药代动力学
Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.
本文引用的文献
1
THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL.多巴胺和多巴在各种动物中的分布及其在不同生物材料中的测定方法。
J Pharmacol Exp Ther. 1964 Sep;145:326-36.
2
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].[左旋多巴（L-3,4-二羟基苯丙氨酸）对帕金森氏症运动不能的作用]
Wien Klin Wochenschr. 1961 Nov 10;73:787-8.
3
[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].[5-羟色胺（血清素）在人脑中的分布及其在帕金森综合征患者中的表现]
Klin Wochenschr. 1961 Oct 15;39:1056-9. doi: 10.1007/BF01487648.
4
Drug-induced changes of extracerebral dopa metabolism in man.
Arch Neurol. 1969 Feb;20(2):187-90. doi: 10.1001/archneur.1969.00480080087010.
5
L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.帕金森病的左旋多巴治疗：血浆左旋多巴浓度、治疗反应及副作用。
Mayo Clin Proc. 1971 Apr;46(4):231-9.
6
L-dopa treatment failure: explanation and correction.左旋多巴治疗失败：解释与纠正。
Br Med J. 1970 Oct 10;4(5727):93-4. doi: 10.1136/bmj.4.5727.93.
7
Metabolism of levodopa in patients with Parkinson's disease. Radioactive and fluorometric assays.帕金森病患者中左旋多巴的代谢。放射性和荧光测定法。
Arch Neurol. 1971 Jul;25(1):39-44. doi: 10.1001/archneur.1971.00490010049007.
8
[Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Med Monatsschr. 1971 Oct;25(10):472-9.
9
[Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
Clin Chim Acta. 1971 Jun;33(1):111-5. doi: 10.1016/0009-8981(71)90257-9.
10
Catecholamine metabolism during oral administration of levodopa.左旋多巴口服给药期间的儿茶酚胺代谢
Arch Neurol. 1972 Mar;26(3):245-52. doi: 10.1001/archneur.1972.00490090071005.
Zotero 插件